These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 341903)

  • 1. Preliminary clinical evaluation of a new topical corticosteroid, halopredone acetate, as compared to fluocinonide.
    Rampini E; Rastelli A; Divano C
    Arzneimittelforschung; 1977; 27(12):2396-9. PubMed ID: 341903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical investigation of halopredone acetate, a new topical steroid, in dermatology. Controlled study.
    Palmerio B; Magnani P
    Arzneimittelforschung; 1977; 27(12):2404-6. PubMed ID: 341905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical study of the relationship between dose and response to halopredone acetate in dermatoses.
    Rampini E; Rastelli A; Divano C
    Arzneimittelforschung; 1977; 27(12):2399-403. PubMed ID: 341904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of non-inflammatory dermatoses. A double-blind comparison of 1% hydrocortisone plus 10% urea and 0.05% fluocinonide.
    Khan SA
    Practitioner; 1978 Aug; 221(1322):265-7. PubMed ID: 364458
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind comparison of topical halcinonide and fluocinonide in the treatment of psoriasis.
    Close JE
    Int J Dermatol; 1976 Sep; 15(7):534-7. PubMed ID: 786910
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative efficacy of halcinonide and fluocinonide creams in psoriasis and eszematous dermatoses.
    Sudilovsky A; Clewe TH
    J Clin Pharmacol; 1975; 15(11-12):779-84. PubMed ID: 1104668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluocinonide vs halcinonide in atopic dermatitis. A paired comparison of two potent topical corticosteroids.
    Silverman A
    Cutis; 1979 Mar; 23(3):375-8. PubMed ID: 369775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasis.
    Willis I; Cornell RC; Penneys NS; Zaias N
    Clin Ther; 1986; 8(3):275-82. PubMed ID: 3521856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluocinonide: a new topical corticosteroid for psoriasis and other dermatoses.
    Counce JH; Brass A
    J La State Med Soc; 1972 Oct; 124(10):365-7. PubMed ID: 5079531
    [No Abstract]   [Full Text] [Related]  

  • 10. Psoriasis: topical corticosteroid therapy.
    Lynfield Y; Watsky M
    Cutis; 1976 Jul; 18(1):133, 136-7. PubMed ID: 797547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discoid lupus erythematosus. Diagnostic features and evaluation of topical corticosteroid therapy.
    Roenigk HH; Martin JS; Eichorn P; Gilliam JN
    Cutis; 1980 Mar; 25(3):281-5. PubMed ID: 6987043
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of halopredone acetate on rat liver tryptophan oxygenase and tyrosine aminotransferase activities.
    Netti C; Bianchetti A; Pecile A
    Arzneimittelforschung; 1977; 27(11):2108-11. PubMed ID: 23791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part II: Comparative study with several commercial preparations (author's transl)].
    Reckers VR; Wendt H
    Arzneimittelforschung; 1976; 26(7b):1504-9. PubMed ID: 795434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New esters of Halopredone for topical antiinflammatory use.
    Toscano L; Grisanti G; Bianchetti A; Bossoni G
    Arzneimittelforschung; 1977; 27(9):1634-5. PubMed ID: 579128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of halopredone acetate, a new topical antiinflammatory steroid.
    Bianchetti A; Bossoni G; Guarneri L; Giudici L; Riva M
    Arzneimittelforschung; 1977; 27(11):2096-102. PubMed ID: 580007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of psoriasis with amcinonide 0.1 percent and fluocinonide 0.05 percent ointments. A comparative double-blind study.
    Engel MF
    Cutis; 1982 Jun; 29(6):646-50. PubMed ID: 7049592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivatives of 2-bromo-6beta-fluoropregna-1,4-diene-3,20-dione and their antiinflammatory activity.
    Toscano L; Barlotti L; Fioriello G; Grisanti G; Bossoni G; Biraschi LM; Riva M
    Arzneimittelforschung; 1977; 27(9):1628-33. PubMed ID: 579127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicological studies on halopredone acetate.
    Casilli L; Sauro M; Biraschi LM; Tarantino P; Michelazzi L
    Arzneimittelforschung; 1977; 27(11):2102-8. PubMed ID: 580008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of desoximetasone ointment 0.25% versus fluocinonide ointment 0.05% in patients with psoriasis.
    Clin Ther; 1985; 8(1):118-25. PubMed ID: 3914368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.